CDC Panel Backs Novavax COVID Vaccine for Adults
The CDC Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend Novavax’s COVID-19 vaccine for individuals 18 and up. With a vote of 12-0, the advisory panel endorsed a two-dose primary series of the adjuvanted, protein-based vaccine, which will be administered 3 weeks apart. The recommendation follows FDA’s emergency use authorization last week. Shortly […]
Long-Denied COVID Vax Lands Authorization
As expected, the FDA has granted an emergency use authorization (EUA) for Novavax’s COVID-19 vaccine in adults, the agency announced on Wednesday. The decision follows a near-unanimous FDA advisory committee recommendation more than a month ago, with the EUA reportedly delayed in order to allow regulators time to review recent changes to the vaccine’s manufacturing […]
FDA Advisers Back Authorization of Novavax COVID Shot
The benefits of Novavax’s adjuvanted protein-based COVID-19 vaccine outweigh the risks, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) said in a near-unanimous vote on Tuesday. With 21 members voting yes, and one abstention, VRBPAC recommended Novavax’s two-dose vaccine for adults, saying that it met the criteria for FDA emergency use authorization (EUA). […]